Neurotoxicology testing

Toxicological Testing Handbook: Principles, Applications and Data Interpretation

Volumn , Issue , 2016, Pages 357-390

  Raffaele, Kathleen C ^a   Weisenburger, Walter P ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b Advanced Neuro Health LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959203128     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (86)

1. London E, Etzel RA. The environment as an etiologie factor in autism: a new direction for research. Environ Health Perspect 2000; 108:401-104.
2. Rice DC. Parallels between attention deficit hyperactivity disorder and behavioral deficits produced by neurotoxic exposure in monkeys. Environ Health Perspect 2000; 108:405-108.
3. Olney JW. New insights and new issues in developmental neurotoxicology. Neurotoxicology 2002; 23:659-668.
4. Weiss B. Vulnerability to pesticide neurotoxicity is a lifetime issue. Neurotoxicology 2000; 21:67-74.
5. National Research Council. Pesticides in the diets of infants and children. Committee on Pesticides in the Diets of Infants and Children. Washington, DC: National Academy Press, 1993.
6. U.S. Congress. Food Quality Protection Act. Public Law 104-170. Washington, DC: Government Printing Office, 1996.
7. U.S. Environmental Protection Agency, Office of Pesticide Programs, Pesticide Assessment Guidelines, Subdivision F-Hazard Evaluation; Human and Domestic Animals. EPA Pub. No. 540/9-82-025, Washington, DC, 1982.
8. U.S. Environmental Protection Agency. Toxic Substances Control Act Test Guidelines: Final Rules. 40 CFR Parts 796-798. September 27 (1985). 39252-39516. Part 798 Subpart G. Neurotoxicity, pp. 39458-39470, 1985.
9. U.S. Environmental Protection Agency. Health Effects Test Guidelines, OPPTS 870-100-870.7800. EPA Document 712-C-98-189 through 712-C-98-351. Washington, DC: U.S. Environmental Protection Agency, 1998.
10. Organization for Economic Cooperation and Development. Test Guideline 424. OECD Guideline for Testing of Chemicals. Neurotoxicity Study in Rodents 1997.
11. U.S. Environmental Protection Agency. Pesticides; data requirement for conventional chemicals. Fed Regist 2005; 70:12276-12353.
12. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline, Safety Pharmacology Studies for Human Pharmaceuticals, S7A, 2000.
13. Sobotka TJ, Ekelman KB, Slikker W, et al. Food and drug administration proposed guidelines for neurotoxicological testing of food chemicals. Neurotoxicology 1996; 17:825-836.
14. U.S. Environmental Protection Agency, Pesticide Assessment Guidelines, Subdivision F-Hazard Evaluation; Human and Domestic Animals, Addendum 10-Neurotoxicity Series 81, 82, and 83; PB 91-154617. Springfield, VA: National Technical Information Service, 1991.
15. U.S. Environmental Protection Agency. Guidelines for neurotoxicity risk assessment. Fed Regist 1998; 63:26926-26954.
16. Organization for Economic Cooperation and Development. Guidance Document for Neurotoxicity Testing. OECD Environment, Health and Safety Publications, Series on Testing and Assessment No. 20, OECD: Paris, 2004.
17. Harry J, Kulig B, Lotti M, et al. Environmental Health Criteria 223: Neurotoxicity risk assessment for human health: Principles and approaches. International Programme on Chemical Safety, World Health Organization, Geneva, 2001.
18. Clarren SK, Smith DW. The fetal alcohol syndrome. N Engl J Med 1978; 298:1063-1067.
19. Chang LW, Guo GL. Fetal minamata disease: congenital methylmercury poisoning. In: Slikker W, Chang LW, eds. Handbook of Developmental Neurotoxicology. San Diego, California: Academic Press, 1998:507-515.
20. Committee on the Safety of Medicines. Notes for guidance on reproduction studies. Committee on the Safety of Medicines. London, Great Britain: Department of Health and Social Security, 1974.
21. Ministry of Health and Welfare. On studies of the effects of drugs on reproduction, Notification No. 529 of the Pharmaceutical Affairs Bureau. Japan: Ministry of Health and Welfare, 1975.
22. U.S. Food Drug Administration, International Conference on Harmonization: Guideline on Detection of Toxicity to Reproduction for Medicinal Products: Availability Notice. Federal Register, September 22, 1994, Part IX, 48746-18752.
23. U.S. Environmental Protection Agency. Health Effects Test Guidelines, OPPTS 870-100 through 870.7800. EPA Document 712-C-98-238. Washington, DC: U.S. Environmental Protection Agency, 1998.
24. Organization for Economic Cooperation and Development, Guideline 407 on repeated dose 28-day oral toxicity study in rodents, OECD: Paris, 1995.
25. Organization for Economic Cooperation and Development, Guideline 408 on repeated dose 90-day oral toxicity study in rodents. OECD: Paris, 1998.
26. Crofton KM, Makris SL, Sette WF, et al. A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies. Neurotoxicol Teratol 2004; 26:345-352.
27. Moser VC, Ross JF, eds. Training video and reference manual for a functional observational battery. U.S. Environmental Protection Agency and American Industrial Health Council, 1996.
28. U.S. Environmental Protection Agency, Generic Non-OP Protocol Review Format (10/21/02). Unpublished document used as template for DNT Study Reviews. Health Effects Division, Office of Pesticide Programs, 2002, p. 7.
29. Moser VC, McCormick SP, Cresson JP, et al. Comparison of chlordimeform and carbaryl using a functional observational battery. Fund Appl Toxicol 1988; 11:139-206.
30. Tilson HA, Moser VC. Comparison of screening approaches. Neurotoxicology 1992; 13:1-14.
31. Crofton KM, Howard JL, Moser VC, et al. Interlaboratory comparisons of motor activity experiments: implications for neurotoxicological measurements. Neurotoxicol Teratol 1991; 13:599-609.
32. Brock TO, O'Callaghan JP. Quantitative changes in the synaptic vesicle proteins, synapsin I and p38 and the astrocyte specific protein, glial fibrillary acidic protein, are associated with chemical induced injury to the rat central nervous system. J Neurosci 1987; 7:931-942.
33. O'Callaghan JP. Neurotypic and gliotypic proteins as biochemical markers of neurotoxicity. Neurotoxicol Teratol 1988; 10:445-452.
34. Spencer PS, Schaumberg HH, eds. Experimental and Clinical Neurotoxicology. Baltimore: Williams and Wilkins, 1980.
35. World Health Organization (WHO), Principles and Methods for the Assessment of Neurotoxicity Associated with Exposure to Chemicals (Environmental Health Criteria 60). World Health Organization Publication Center U.S.A., Albany, New York, 1986.
36. U.S. Environmental Protection Agency, Office of Prevention, Pesticides, and Toxic Substances. Developmental Neurotoxicity Guideline OPPTS 870.6300, EPA Document 712-C-98-239. Washington, DC, 1998.
37. U.S. Environmental Protection Agency, Office of Prevention, Pesticides and Toxic Substances, Office of Pesticide Programs. Data Call-in Notice, Attachment F. U.S. Environmental Protection Agency, Washington, DC: Sept. 10, 1999.
38. Organization for Economic Cooperation and Development. OECD Guideline for the Testing of Chemicals, Draft Proposal for a New Guideline 426, Developmental Neurotoxicity Study. Environment Directorate, OECD: Paris, May 2005.
39. Agnish ND, Keller KA. The rationale for culling of rodent litters. Fund Appl Toxicol 1997; 38:2-6.
40. Lore R, Avis H. Effects of auditory stimulation and litter size upon subsequent emotional behavior in the rat. Dev Psychobiol 1970; 2:212-215.
41. Palmer AK. A simpler multi-generation study. International Congress of Pesticide Chemistry, 1986:1-20.
42. Zoetis T, Walls I. Principles and Practices for Direct Dosing of Pre-Weaning Mammals in Toxicity Testing and Research. Washington, DC: ILSI Press, 2003.
43. Adams J, Buelke-Sam J, Kimmel CA, et al. Collaborative behavioral teratology study: protocol design and testing procedure. Neurobehav Toxicol Teratol 1985; 7:579-586.
44. Korenbrot CC, Huhtaniemi IT, Weiner RW. Preputial separation as an external sign of pubertal development in the male rat. Biol Reprod 1977; 17:298-303.
45. Butcher RE. Behavioral testing as a method for assessing risk. Environ Health Perspect 1976; 18:75-78.
46. Ruppert PH, Dean KF, Reiter LW. Development of locomotor activity of rat pups in figure-eight mazes. Dev Psychobiol 1984; 18:247-260.
47. Ison JR. Reflex modification as an objective test for sensory processing following toxicant exposure. Neurobehav Toxicol Teratol 1984; 6:437-445.
48. Green RJ, Stanton ME. Differential ontogeny of working memory and reference memory in the rat. Behav Neurosci 1989; 103:98-105.
49. Kucharski D, Spear NE. Conditioning of aversion to an odor paired with peripheral shock in the developing rat. Dev Psychobiol 1984; 17:465-479.
50. Cory-Slechta DA, Weiss B, Cox C. Delayed behavioral toxicity of lead with increasing exposure concentration. Toxicol Appl Pharmacol 1983; 71:342-352.
51. Spear NE, Campbell BA, eds. Ontogeny of Learning and Memory. New Jersey: Erlbaum, 1979.
52. Krasnegor NA, Blass EM, Hoffer MA, et al. Perinatal Development: A Psychobiological Perspective. Orlando, FL: Academic Press, 1987.
53. Miller DB, Eckerman DA. Learning and memory measures. In: Annau Z, ed. Neurobehavioral Toxicology. Baltimore: Johns Hopkins University Press, 1986:94-149.
54. Riley EP, Vorhees CV, eds. Handbook of Behavioral Teratology. New York: Plenum Press, 1986.
55. Morris RGM. Spatial localization does not require the presence of local cues. Learn Motiv 1981; 12:239-260.
56. DeQuervain DJF, Roozendaal B, McGaugh JL. Stress and glucocorticoids impair retrieval of long term spatial memory. Nature 1998; 394:787-790.
57. Vorhees CV, Weisenburger WP, Acuff-Smith KD, et al. An analysis of factors influencing complex water maze learning in rats: effects of task complexity, path order, and escape assistance on performance following prenatal exposure to phenytoin. Neurotoxicol Teratol 1991; 13:213-222.
58. Weisenburger WP, Minck DR, Acuff KD, et al. Dose-response effects of prenatal phenytoin exposure in rats: effects on early locomotion, maze learning, and memory as a function of phenytoin-induced circling behavior. Neurotoxicol Teratol 1990; 12:145-152.
59. Akaike M, Ohno H, Tsutsumi S, et al. Comparison of four spatial maze learning tests with methylnitrosourea-induced microcephaly rats. Teratol 1994; 49:83-89.
60. Tsutsumi S, Akaike M, Ohno H, et al. Learning/memory impairments in rat offspring prenatally exposed to phenytoin. Neurotoxicol Teratol 1998; 20:123-137.
61. Weisenburger WP, Kozsk CL, Hagler AR, et al. Perinatal phenytoin and methimazole in rats to compare five tests of learning and memory: factors relevant to the selection of tests for pharmaceutical safety evaluation. Neurotoxicol Teratol 1997; 19:257-258.
62. Armed Forces Institute of Pathology (AFIP). Manual of Histologic Staining Methods. New York: McGraw-Hill, 1968.
63. Pender MP. A simple method for high resolution light microscopy of nervous tissue. J Neurosci Methods 1985; 15:213-218.
64. Bennet HS, Wyrick AD, Lee SW, et al. Science and art in the preparation of tissues embedded in plastic for light microscopy, with special reference to glycol methacrylate, glass knives, and simple stains. Stain Technol 1976; 51:71-97.
65. Friede RL. Developmental Neuropathology. New York: Springer-Verlag, 1975.
66. Suzuki K. Special vulnerabilities of the developing nervous system to toxic substances. In: Spencer PS, Schaumberg HH, eds. Experimental and Clinical Neurotoxicology. Baltimore: Williams and Wilkins, 1980:48-61.
67. Garmen RH, Fix AS, Jortner BS, et al. Methodsto identify and characterize developmental neurotoxicity for human health risk assessment. II: neuropathology. Environ Health Perspect 2001; 109:93-100.
68. Rodier PM, Gramann WJ. Morphologic effects of interference with cell proliferation in the early fetal period. Neurobehav Toxicol 1979; 1:129-135.
69. Duffel SJ, Soames AR, Gunby S. Morphometric analysis of the developing rat brain. Toxicol Pathol 2000; 28:157-163.
70. Raffaele K, Sette W, Doherty J, et al. Neuropathological findings in developmental neurotoxicity testing: comparison of qualitative and quantitative evaluations. Society of Toxicology, New Orleans, LA, March 2005. Also in The Toxicologist, 2005; 84:200.
71. Tukey JW, Ciminera JL, Heyes JF. Testing the statistical certainty of a response to increasing doses of a drug. Biometrics 1985; 41:295-301.
72. Baird JS, Catalano PJ, Ryan LM, Evans JS. Evaluation of effect profiles: functional observational battery outcomes. Fund Appl Pharmacol 1997; 40:37-51.
73. Koch M. The neurobiology of startle. Prog Neurobiol 1999; 59:107-128.
74. Davis M. The mammalian startle response. Neural Mechanisms ofStartle BehaviorIn: Evans R, ed. New York: Plenum, 1984.
75. Crofton KM, Janssen R, Prazma J, et al. The ototoxicity of 3, 3′ iminopropionitrile: functional and morphological evidence of cochlear damage. Hear Res 1994; 80:129-140.
76. Raffaele K, Gilbert M, Crofton K, et al. Learning and memory tests in developmental neurotoxicity testing: a cross-laboratory comparison of control data. Society of Toxicology, Baltimore, MD, March 2004. Also in The Toxicologist, 2004; 78:276.
77. Streissguth AP, Barr HM, Martin DC. Alcohol exposure in utero and functional deficits in children during the first four years of life. In: Porter R, O'Connor M, Whalen J, eds. Mechanisms of Alcohol Damage in Utero. London: Pitman (Ciba Foundation Symposium 105), 1984.
78. Adams J, Lammer EJ. Relationship between dysmorphology and neuro-psychological function in children exposed to isotretinoin "in utero." Clin Neuropharm 1991; 13:159-168.
79. Adams J, Holson RR. The neurobehavioral teratology of vitamin A analogs. In: Slikker W, Chang LW, eds. Handbook of Developmental Neurotoxicology. San Diego, California: Academic Press, 1998:631-642.
80. Hyman BT, Gomez-Isla T, Irizarry MC. Stereology: a practical primer for neuropathology. J Neuropathol Exp Neurol 1998; 57:305-310.
81. West MJ. Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci 1999; 22:51-61.
82. Stanton ME, Spear LP. Workshop on the Qualitative and Quantitative Comparability of Human and Animal Developmental Neurotoxicity, Work Group I Report: Comparability of Measures of Developmental Neurotoxicity in Humans and Laboratory Animals. Neurotoxicol Teratol 1990; 12:261-267.
83. Paule MG. Using identical behavioral tasks in children, monkeys, and rats to study the effects of drugs. Curr Ther Res 2001; 62:820-833.
84. Chalonis JJ, Daniels-Shaw JL, Blake DJ, et al. Developmental aspects of delayed matching-to-sample task performance in children. Neurotox Teratol 2000; 22:684-694.
85. Cory-Slechta DA, Crofton KM, Foran JA, et al. Methods to identify and characterize developmental neurotoxicity for human health risk assessment. I. Behavioral effects. Environ Health Perspect 2001; 109:79-91.
86. Dorman DC, Allen SL, Byczkowski JZ, et al. Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III. Pharmacokinetic and pharmacodynamic considerations. Environ Health Perspect 2001; 109:101-111.